Results 11 to 20 of about 11,770,891 (406)

Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease [PDF]

Zhongguo quanke yixue, 2022
China has attached importance to the prevention and treatment of chronic obstructive pulmonary disease (COPD) , a major chronic respiratory disease. An in-depth discussion of the immunopathogenesis of COPD and intervening the identified key targets may ...
Writing Group for the Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease
doaj   +1 more source

Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) [PDF]

Zhongguo quanke yixue, 2023
Chronic obstructive pulmonary disease (COPD) is one of the major chronic disease seriously affecting the health of Chinese residents. There are national and international guidelines and consensus on the diagnosis, treatment and management of COPD ...
Expert Consensus Writing Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease
doaj   +1 more source

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

European Respiratory Journal, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites.
C. Daley, J. Iaccarino, C. Lange, E. Cambau, R. Wallace, C. Andrejak, E. Böttger, J. Brożek, D. Griffith, L. Guglielmetti, G. Huitt, Shandra L. Knight, P. Leitman, T. Marras, K. Olivier, M. Santin, J. Stout, E. Tortoli, J. van Ingen, D. Wagner, K. Winthrop   +20 more
semanticscholar   +2 more sources

Sleep Hypoventilation is Common in Diurnal Normocapnic COPD Patients with Severe or Very Severe Obstruction and is Not Associated with Body Mass Index

COPD, 2023
Sleep hypoventilation (SH) is common in COPD patients with diurnal hypercapnia, however there are little data on the presence of SH in COPD patients with diurnal normocapnia.
Safir Zewari, Bram van den Borst, Michel van den Heuvel, Frank van den Elshout, Manu Sastry, Petra Vos   +5 more
doaj   +1 more source

Current status of diagnosis and treatment of pulmonary hypertension in Chinese tertiary hospitals: A nationwide survey

Pulmonary Circulation, 2023
We intended to evaluate the diagnosis and treatment status of pulmonary hypertension (PH) in China and provide the basis for the design of the Chinese PH centers system.
Meng Zhang, Wanmu Xie, Yao Xiao, Wei Guo, Yan Wang, Wenmei Zhang, Shengchen Duan, Qian Gao, Shuai Zhang, Yunxia Zhang, Xueran Guo, Ao Yin, Jiafei Peng, Jun Wan, Zhenguo Zhai, Group of Pulmonary Embolism and Pulmonary Vascular Disease, Chinese Thoracic Society; Working Committee of Pulmonary Embolism and Pulmonary Vascular Disease, Chinese Association of Chest Physicians; Expert Committee, National Project of Standardized Diagnosis and Treatment of Pulmonary Hypertension   +15 more
doaj   +1 more source

PULMONARY ANGIOGRAPHY IN PULMONARY EMBOLIC DISEASE [PDF]

American Journal of Roentgenology, 1967
Pulmonary emboli were produced in 15 dogs and studied with serial angiography. The most common angiographic sign in the embolized animal was a filling defect and/or a cut-off, with or without regional delay in arterial flow. Less common findings were regional hypovascularity, slow arterial washout with capillary staining, tapered arteries, and beading ...
E J, Ferris, R M, Stanzler, J A, Rourke, J, Blumenthal, J V, Messer   +4 more
openaire   +2 more sources

Pulmonary hypertension phenotypes in patients with systemic sclerosis

European Respiratory Review, 2021
Pulmonary hypertension (PH) commonly affects patients with systemic sclerosis (SSc) and is associated with significant morbidity and increased mortality.
Ashraful Haque, David G. Kiely, Gabor Kovacs, A.A. Roger Thompson, Robin Condliffe   +4 more
doaj   +1 more source

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Blood, 2021
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related phenomenon that induces inflammation. Since CHIP is a risk factor for cardiovascular disease, Miller and colleagues investigated the association between CHIP and chronic obstructive
P. Miller, D. Qiao, J. Rojas-Quintero, M. Honigberg, A. Sperling, C. Gibson, A. Bick, A. Niroula, M. McConkey, Brittany Sandoval, Brian C Miller, Weiwei Shi, Kaushik Viswanathan, Matthew J. Leventhal, L. Werner, M. Moll, B. Cade, R. Barr, A. Correa, L. Cupples, Sina A. Gharib, D. Jain, S. Gogarten, L. Lange, Stephanie A. London, A. Manichaikul, G. O'Connor, E. Oelsner, S. Redline, S. Rich, J. Rotter, V. Ramachandran, B. Yu, L. Sholl, D. Neuberg, S. Jaiswal, B. Levy, C. Owen, P. Natarajan, E. Silverman, Peter van Galen, Y. Tesfaigzi, M. Cho, B. Ebert   +43 more
semanticscholar   +1 more source

Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension

Pulmonary Circulation, 2022
Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (PH) are at increased risk when undergoing anesthesia and major surgery. Data on outcomes for elective orthopedic surgery in patients with PH are limited.
Mikaela Wardle, Amanda Nair, Sarah Saunders, Iain Armstrong, Athanasios Charalampopoulos, Charlie Elliot, Abdul Hameed, Neil Hamilton, John Harrington, Carol Keen, Robert Lewis, Ian Sabroe, A. A. Roger Thompson, Robert M. Kerry, Robin Condliffe, David G. Kiely   +15 more
doaj   +1 more source

Management of Chronic Obstructive Pulmonary Disease

Handbook of Healthcare in the Arab World, 2021
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity throughout the world. It is the only cause of death among the top ten causes that is increasing and is expected to become the third leading cause of death in the ...
Maher R. Khdour, Hussein O. Hallak, Hani Abdeen   +2 more
semanticscholar   +1 more source